Odor identification in frontotemporal lobar degeneration subtypes
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
24939002
PubMed Central
PMC10852957
DOI
10.1177/1533317514539033
PII: 1533317514539033
Knihovny.cz E-zdroje
- Klíčová slova
- behavioral variant frontotemporal dementia, cognitive status, odor identification, primary nonfluent aphasia, progressive supranuclear palsy, semantic dementia,
- MeSH
- frontotemporální demence komplikace patofyziologie MeSH
- frontotemporální lobární degenerace komplikace patofyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- neuropsychologické testy MeSH
- odoranty * MeSH
- poruchy čichu komplikace patofyziologie MeSH
- primární progresivní nonfluentní afázie komplikace patofyziologie MeSH
- progresivní supranukleární obrna komplikace patofyziologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- stupeň závažnosti nemoci MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Odor identification impairment is a feature of several neurodegenerative disorders. Although neurodegenerative changes in the frontotemporal lobar degeneration (FTLD) subtypes involve areas important for olfactory processing, data on olfactory function in these patients are limited. An 18-item, multiple-choice odor identification test developed at our memory clinic, the Motol Hospital smell test, was administered to 9 patients with behavioral variant frontotemporal dementia, 13 patients with the language variants, primary nonfluent aphasia (n = 7) and semantic dementia (n = 6), and 8 patients with progressive supranuclear palsy. Compared to the control group (n = 15), all FTLD subgroups showed significant impairment of odor identification (P < .05). The differences between the FTLD subgroups were not significant. No correlation between odor identification and neuropsychological tests results was found. Our data suggest that odor identification impairment is a symptom common to FTLD syndromes, and it seems to be based on olfactory structure damage rather than cognitive decline.
Zobrazit více v PubMed
Ansari KA, Johnson AJ. Olfactory function in patients with Parkinson’s disease. J Chronic Dis. 1975;28 (9):493–497. PubMed
Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1992;55 (2):138–142. PubMed PMC
Tissingh G, Berendse HW, Bergmans P, et al. . Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord. 2011;16 (1):41–46. PubMed
Bylsma FW, Moberg PJ, Doty RL, Brandt J. Odor identification in Huntington's disease patients and asymptomatic gene carriers. J Neuropsychiatry Clin Neurosci. 1997;9 (4):598–600. PubMed
Moberg PJ, Doty RL. Olfactory function in Huntington's disease patients and at-risk offspring. Int J Neurosci. 1997;89 (1-2):133–139. PubMed
Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 1987;18 (5):597–600. PubMed
Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2008;29 (5):693–706. PubMed
Devanand DP, Michaels-Marston KS, Liu X, et al. . Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry. 2000;157 (9):1399–1405. PubMed
Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci. 2009;1170:730–735. PubMed PMC
Hodges JR, Davies RR, Xuereb JH, et al. . Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56 (3):399–406. PubMed
Pereira JM, Williams GB, Acosta-Cabronero J, et al. . Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration. Neurology. 2009;72 (19):1653–1660. PubMed PMC
Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 2007;114 (1):31–38. PubMed
Neary D, Snowden JS, Gustafson L, et al. . Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51 (6):1546–1554. PubMed
McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol. 2001;58 (11):1803–1809. PubMed
Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128 (pt 9):1996-2005. PubMed
Kumar-Singh S, Van Broeckhoven C. Frontotemporal lobar degeneration: current concepts in the light of recent advances. Brain Pathol. 2007;17 (1):104–113. PubMed PMC
Jones-Gotman M, Zatorre RJ, Cendes F, et al. . Contribution of medial versus lateral temporal-lobe structures to human odour identification. Brain. 1997;120 (pt 10):1845–1856. PubMed
Öngür D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000;10 (3):206–219. PubMed
Shepherd GM. Smell images and the flavour system in the human brain. Nature. 2006;444 (7117):316–321. PubMed
Sobel N, Prabhakaran V, Desmond JE, et al. . Sniffing and smelling: separate subsystems in the human olfactory cortex. Nature. 1998;392 (6673):282–286. PubMed
Zatorre RJ, Jones-Gotman M, Evans AC, Meyer E. Functional localization and lateralization of human olfactory cortex. Nature. 1992;360 (6402):339–340. PubMed
Benarroch EE. Olfactory system functional organization and involvement in neurodegenerative disease. Neurology. 2010;75 (12):1104–1109. PubMed
Jones-Gotman M, Zatorre RJ. Olfactory identification deficits in patients with focal cerebral excision. Neuropsychologia. 1988;26 (3):387–400. PubMed
Frisoni GB, Laakso MP, Beltramello A, et al. . Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology. 1999;52 (1):91–100. PubMed
Kril JJ, Halliday GM. Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy. Dement Geriatr Cogn Disord. 2004;17 (4):311–315. PubMed
Seeley WW, Crawford R, Rascovsky K, et al. . Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol. 2008;65 (2):249–255. PubMed PMC
Yoshimura N. Olfactory bulb involvement in Pick's disease. Acta Neuropathol. 1988;77 (2):202–205. PubMed
Schroeter ML, Raczka K, Neumann J, Von Cramon DY. Neural networks in frontotemporal dementia—a meta-analysis. Neurobiol Aging. 2008;29 (3):418–426. PubMed
Josephs KA, Duffy JR, Strand EA, et al. . Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006;129 (pt 6):1385–13 98. PubMed PMC
Nestor PJ, Graham NL, Fryer TD, Williams GB, Patterson K, Hodges JR. Progressive non-fluent aphasia is associated with hypometabolism centered on the left anterior insula. Brain. 2003;126 (pt 11):2406–24 18. PubMed
Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. . Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55 (3):335–346. PubMed PMC
Schroeter ML, Raczka K, Neumann J, Von Cramon DY. Towards a nosology for frontotemporal lobar degenerations—a meta-analysis involving 267 subjects. Neuroimage. 2007;36 (3):497–510. PubMed
Brambati SM, Rankin KP, Narvid J, et al. . Atrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry study. Neurobiol Aging. 2009;30 (1):103–111. PubMed PMC
Turner RS, Kenyon LC, Trojanowski JQ, Gonatas N, Grossman M. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Ann Neurol. 1996;39 (2):166–173. PubMed
Litvan I, Agid Y, Calne D, et al. . Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47 (1):1–9. PubMed
Bigio EH, Vono MB, Satumtira S, et al. . Cortical synapse loss in progressive supranuclear palsy. J Neuropathol Exp Neurol. 2001;60 (5):403–410. PubMed
Giordano A, Tessitore A, Corbo D, et al. . Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy. Parkinsonism Relat Disord. 2013;19 (6):590–594. PubMed
Rohrer JD, Paviour D, Bronstein AM, O'sullivan SS, Lees A, Warren JD. Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord. 2010;25 (2):179–188. PubMed PMC
Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia. 2007;45 (8):1823–1831. PubMed
Omar R, Mahoney CJ, Buckley AH, Warren JD. Flavour identification in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry. 2013;84 (1):88–93. PubMed PMC
McLaughlin NC, Westervelt HJ. Odor identification deficits in frontotemporal dementia: a preliminary study. Arch Clin Neuropsychol. 2008;23 (1):119–123. PubMed
Pardini M, Huey ED, Cavanagh AL, Grafman J. Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch Neurol. 2009;66 (1):92–96. PubMed PMC
Rami L, Loy CT, Hailstone J, Warren JD. Odour identification in frontotemporal lobar degeneration. J Neurol. 2007;254 (4):431–435. PubMed PMC
Piwnica-Worms KE, Omar R, Hailstone JC, Warren JD. Flavour processing in semantic dementia. Cortex. 2010;46 (6):761–768. PubMed PMC
Olofsson JK, Rogalski E, Harrison T, Mesulam MM, Gottfried JA. A cortical pathway to olfactory naming: evidence from primary progressive aphasia. Brain. 2013;136 (pt 4):1245–1259. PubMed PMC
Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology. 1993;43 (5):962–965. PubMed
Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, Urashima M. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy. BMC Neurol. 2011;11:157. PubMed PMC
Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand. 1995;91 (4):247–250. PubMed
Müller A, Müngersdorf M, Reichmann H, Strehle G, Hummel T. Olfactory function in Parkinsonian syndromes. J Clin Neurosci. 2002;9 (5):521–524. PubMed
Silveira-Moriyama L, Hughes G, Church A, et al. . Hyposmia in progressive supranuclear palsy. Mov Disord. 2010;25 (5):570–577. PubMed
Magerova H, Vyhnalek M, Laczo J, Bojar M, Hort J. Odor perception testing in early diagnosis of neurodegenerative dementia. Cesk Neurol Neurochir. 2008;71:298–302.
Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94 (2 pt 1):176–178. PubMed
Vollmecke TA, Doty RL. Development of the Picture Identification Test (PIT): a research companion to the University of Pennsylvania Smell Identification Test. Chem Senses. 1985;10:413–414.
Kettenmann B, Hummel C, Stefan H, Kobal G. Multiple olfactory activity in the human neocortex identified by magnetic source imaging. Chem Senses. 1997;22 (5):493–502. PubMed
Doty RL, Applebaum S, Zusho H, Settle RG. Sex differences in odor identification ability: a cross-cultural analysis. Neuropsychologia. 1985;23 (5):667–672. PubMed